Companies included in BIB
This is BIB's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–100 of 278.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 39,904 | NS | 6.480963% |
| N/A | N/A | 4,291 | NC | 6.343886% |
| VRTX | Vertex Pharmaceuticals, Inc. | 11,581 | NS | 6.273884% |
| AMGN | Amgen, Inc. | 14,536 | NS | 6.152311% |
| REGN | Regeneron Pharmaceuticals, Inc. | 4,769 | NS | 4.064745% |
| N/A | N/A | 2,484 | NC | 3.607338% |
| N/A | N/A | 2,639 | NC | 2.890727% |
| N/A | N/A | 6,179 | NC | 2.85019% |
| N/A | N/A | 3,646 | NC | 2.632957% |
| ALNY | Alnylam Pharmaceuticals, Inc. | 6,101 | NS | 2.214744% |
| INVESCO GOVT AND AGCY LEX | INVESCO GOVT AND AGCY LEX | 1,662,868.5 | NS | 1.813178% |
| Repurchase Agreement | Repurchase Agreement | 1,567,850.91 | PA | 1.709572% |
| INSM | Insmed, Inc. | 9,848 | NS | 1.603532% |
| BIIB | Biogen, Inc. | 6,774 | NS | 1.416843% |
| ARGX | Argenx SE | 1,344 | NS | 1.123911% |
| UTHR | United Therapeutics Corp. | 1,988 | NS | 1.092303% |
| MRNA | Moderna, Inc. | 18,039 | NS | 1.053699% |
| ILMN | Illumina, Inc. | 7,055 | NS | 1.034362% |
| ROIV | Roivant Sciences Ltd. | 32,114 | NS | 1.013387% |
| INCY | Incyte Corp. | 9,065 | NS | 1.000993% |
| RPRX | Royalty Pharma plc | 19,729 | NS | 0.994085% |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | 8,927 | NS | 0.993055% |
| VTRS | Viatris, Inc. | 53,183 | NS | 0.865795% |
| Repurchase Agreement | Repurchase Agreement | 776,975.55 | PA | 0.847208% |
| Repurchase Agreement | Repurchase Agreement | 776,975.55 | PA | 0.847208% |
| ASND | Ascendis Pharma A/S | 2,835 | NS | 0.721809% |
| NBIX | Neurocrine Biosciences, Inc. | 4,604 | NS | 0.663917% |
| IONS | Ionis Pharmaceuticals, Inc. | 7,479 | NS | 0.661782% |
| Sanofi SA | Sanofi SA | 12,219 | NS | 0.648321% |
| BBIO | Bridgebio Pharma, Inc. | 8,897 | NS | 0.644937% |
| MEDP | Medpace Holdings, Inc. | 1,301 | NS | 0.640867% |
| SMMT | Summit Therapeutics, Inc. | 34,375 | NS | 0.62183% |
| GH | Guardant Health, Inc. | 5,974 | NS | 0.611665% |
| BMRN | BioMarin Pharmaceutical, Inc. | 8,871 | NS | 0.597106% |
| EXEL | Exelixis, Inc. | 12,381 | NS | 0.594816% |
| JAZZ | Jazz Pharmaceuticals plc | 2,806 | NS | 0.581393% |
| BNTX | BioNTech SE | 4,669 | NS | 0.561185% |
| Repurchase Agreement | Repurchase Agreement | 466,185.33 | PA | 0.508325% |
| Repurchase Agreement | Repurchase Agreement | 466,185.33 | PA | 0.508325% |
| BeOne Medicines Ltd. | BeOne Medicines Ltd. | 1,454 | NS | 0.502565% |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,048 | NS | 0.49366% |
| IBRX | ImmunityBio, Inc. | 45,481 | NS | 0.485011% |
| TEM | Tempus AI, Inc. | 7,982 | NS | 0.463462% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 6,271 | NS | 0.432631% |
| PRAX | Praxis Precision Medicines, Inc. | 1,155 | NS | 0.424104% |
| Repurchase Agreement | Repurchase Agreement | 388,487.77 | PA | 0.423604% |
| AXSM | Axsome Therapeutics, Inc. | 2,327 | NS | 0.415845% |
| HALO | Halozyme Therapeutics, Inc. | 5,430 | NS | 0.411675% |
| PCVX | Vaxcyte, Inc. | 6,044 | NS | 0.406887% |
| KRYS | Krystal Biotech, Inc. | 1,339 | NS | 0.402444% |
| CYTK | Cytokinetics, Inc. | 5,646 | NS | 0.383048% |
| Nuvalent, Inc. | Nuvalent, Inc. | 3,335 | NS | 0.370737% |
| Abivax SA | Abivax SA | 2,726 | NS | 0.360494% |
| Repurchase Agreement | Repurchase Agreement | 310,790.22 | PA | 0.338883% |
| Repurchase Agreement | Repurchase Agreement | 310,790.22 | PA | 0.338883% |
| Arcellx, Inc. | Arcellx, Inc. | 2,670 | NS | 0.331282% |
| KYMR | Kymera Therapeutics, Inc. | 3,322 | NS | 0.330895% |
| RYTM | Rhythm Pharmaceuticals, Inc. | 3,082 | NS | 0.311627% |
| COGT | Cogent Biosciences, Inc. | 7,088 | NS | 0.30026% |
| PTGX | Protagonist Therapeutics, Inc. | 2,887 | NS | 0.289864% |
| CRSP | CRISPR Therapeutics AG | 4,400 | NS | 0.288535% |
| CAI | Caris Life Sciences, Inc. | 13,029 | NS | 0.286123% |
| PTCT | PTC Therapeutics, Inc. | 3,707 | NS | 0.27563% |
| ALKS | Alkermes plc | 7,624 | NS | 0.250226% |
| IMVT | Immunovant, Inc. | 8,094 | NS | 0.244735% |
| CGON | CG oncology, Inc. | 3,725 | NS | 0.238829% |
| MIRM | Mirum Pharmaceuticals, Inc. | 2,373 | NS | 0.2388% |
| SRRK | Scholar Rock Holding Corp. | 4,710 | NS | 0.227359% |
| Amicus Therapeutics, Inc. | Amicus Therapeutics, Inc. | 14,247 | NS | 0.223235% |
| AMRX | Amneal Pharmaceuticals, Inc. | 14,516 | NS | 0.218586% |
| GPCR | Structure Therapeutics, Inc. | 3,086 | NS | 0.211924% |
| ACAD | ACADIA Pharmaceuticals, Inc. | 7,812 | NS | 0.209206% |
| INDV | Indivior Pharmaceuticals, Inc. | 5,763 | NS | 0.20561% |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | 5,236 | NS | 0.202451% |
| Ligand Pharmaceuticals, Inc. | Ligand Pharmaceuticals, Inc. | 909 | NS | 0.196558% |
| CRNX | Crinetics Pharmaceuticals, Inc. | 4,382 | NS | 0.19638% |
| ERAS | Erasca, Inc. | 13,101 | NS | 0.195136% |
| APGE | Apogee Therapeutics, Inc. | 2,532 | NS | 0.193261% |
| Terns Pharmaceuticals, Inc. | Terns Pharmaceuticals, Inc. | 4,160 | NS | 0.191058% |
| ADMA | ADMA Biologics, Inc. | 10,990 | NS | 0.186582% |
| Repurchase Agreement | Repurchase Agreement | 155,395.11 | PA | 0.169442% |
| XENE | Xenon Pharmaceuticals, Inc. | 3,568 | NS | 0.168187% |
| SYRE | Spyre Therapeutics, Inc. | 3,583 | NS | 0.168035% |
| ARQT | Arcutis Biotherapeutics, Inc. | 5,656 | NS | 0.166331% |
| EWTX | Edgewise Therapeutics, Inc. | 4,889 | NS | 0.162273% |
| TARS | Tarsus Pharmaceuticals, Inc. | 1,961 | NS | 0.161481% |
| SUPN | Supernus Pharmaceuticals, Inc. | 2,648 | NS | 0.158025% |
| DNLI | Denali Therapeutics, Inc. | 6,772 | NS | 0.156396% |
| VCYT | Veracyte, Inc. | 3,650 | NS | 0.145626% |
| BEAM | Beam Therapeutics, Inc. | 4,685 | NS | 0.145388% |
| ALMS | Alumis, Inc. | 4,489 | NS | 0.145326% |
| TWST | Twist Bioscience Corp. | 2,823 | NS | 0.144428% |
| IDYA | Ideaya Biosciences, Inc. | 4,048 | NS | 0.142128% |
| TXG | 10X Genomics, Inc. | 5,379 | NS | 0.135193% |
| TVTX | Travere Therapeutics, Inc. | 4,131 | NS | 0.134186% |
| Apellis Pharmaceuticals, Inc. | Apellis Pharmaceuticals, Inc. | 5,839 | NS | 0.133448% |
| VERA | Vera Therapeutics, Inc. | 2,950 | NS | 0.131207% |
| Centessa Pharmaceuticals plc | Centessa Pharmaceuticals plc | 4,455 | NS | 0.130478% |
| IRON | Disc Medicine, Inc. | 1,744 | NS | 0.126687% |
| ADPT | Adaptive Biotechnologies Corp. | 7,049 | NS | 0.123132% |
SEC N-PORT snapshot as of .